BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 18165897)

  • 21. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
    Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
    Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node.
    Van den Eynden GG; Vandenberghe MK; van Dam PJ; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5391-7. PubMed ID: 17875768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice.
    Yoshihara E; Smeets A; Laenen A; Reynders A; Soens J; Van Ongeval C; Moerman P; Paridaens R; Wildiers H; Neven P; Christiaens MR
    Breast; 2013 Jun; 22(3):357-61. PubMed ID: 23022046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of lymph node metastasis in the systemic dissemination of breast cancer.
    Nathanson SD; Kwon D; Kapke A; Alford SH; Chitale D
    Ann Surg Oncol; 2009 Dec; 16(12):3396-405. PubMed ID: 19657697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?
    Ragage F; Debled M; MacGrogan G; Brouste V; Desrousseaux M; Soubeyran I; de Lara CT; Mauriac L; de Mascarel I
    Cancer; 2010 Jul; 116(13):3093-101. PubMed ID: 20564641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
    Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
    BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.
    Hashizume S; Nagayasu T; Hayashi T; Hidaka S; Tsuchiya T; Tagawa T; Yamasaki N; Furukawa K; Matsumoto K; Miyazaki T
    Lung Cancer; 2009 Sep; 65(3):363-70. PubMed ID: 19157635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
    Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting nodal status in invasive breast cancer: a retrospective analysis of 623 patients.
    Aitken E; Osman M
    Breast J; 2010; 16(3):271-8. PubMed ID: 20210804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.
    Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H
    J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
    Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
    Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.
    Lee AH; Pinder SE; Macmillan RD; Mitchell M; Ellis IO; Elston CW; Blamey RW
    Eur J Cancer; 2006 Feb; 42(3):357-62. PubMed ID: 16377180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of lymphovascular invasion on lymph node status in patients with breast cancer.
    Cornwell LB; McMasters KM; Chagpar AB
    Am Surg; 2011 Jul; 77(7):874-7. PubMed ID: 21944350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
    Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
    J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
    Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
    Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
    Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN
    Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis.
    Nakagawa T; Huang SK; Martinez SR; Tran AN; Elashoff D; Ye X; Turner RR; Giuliano AE; Hoon DS
    Cancer Res; 2006 Dec; 66(24):11825-30. PubMed ID: 17178879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
    Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
    Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.